These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26964999)

  • 1. Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina.
    Leibundgut G; Lee JH; Strauss BH; Segev A; Tsimikas S
    J Thromb Thrombolysis; 2016 May; 41(4):569-80. PubMed ID: 26964999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
    Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
    Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
    Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
    Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.
    DeFilippis AP; Chernyavskiy I; Amraotkar AR; Trainor PJ; Kothari S; Ismail I; Hargis CW; Korley FK; Leibundgut G; Tsimikas S; Rai SN; Bhatnagar A
    J Thromb Thrombolysis; 2016 Jul; 42(1):61-76. PubMed ID: 26510751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A; Gössl M; Hoyt J; Lennon RJ; Polk L; Simari R; Holmes DR; Rihal CS; Lerman A
    Catheter Cardiovasc Interv; 2013 May; 81(6):930-6. PubMed ID: 22517646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of a comprehensive panel of plasma oxidized low-density lipoprotein markers to angiographic restenosis in patients undergoing percutaneous coronary intervention for stable angina.
    Segev A; Strauss BH; Witztum JL; Lau HK; Tsimikas S
    Am Heart J; 2005 Nov; 150(5):1007-14. PubMed ID: 16290986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
    Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention for poor coronary microcirculation reperfusion of patients with stable angina pectoris.
    Li JS; Zhao XJ; Ma BX; Wang Z
    J Biol Regul Homeost Agents; 2016; 30(3):733-741. PubMed ID: 27655490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Serum Malondialdehyde-Modified Low-Density Lipoprotein and Coronary Angiographic Progression After Drug-Eluting Stent Implantation in Patients With Stable Angina.
    Yokoi M; Ito T; Fujita H; Sugiura T; Seo Y; Ohte N
    Circ J; 2020 Sep; 84(10):1837-1845. PubMed ID: 32863287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina.
    Goldberg A; Zinder O; Zdorovyak A; Diamond E; Lischinsky S; Gruberg L; Markiewicz W; Beyar R; Aronson D
    Am Heart J; 2003 Nov; 146(5):819-23. PubMed ID: 14597930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina.
    Gajos G; Zalewski J; Mostowik M; Konduracka E; Nessler J; Undas A
    Nutr Metab Cardiovasc Dis; 2014 Apr; 24(4):434-9. PubMed ID: 24555913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malondialdehyde-modified low-density lipoprotein is a predictor of cardiac events in patients with stable angina on lipid-lowering therapy after percutaneous coronary intervention using drug-eluting stent.
    Ito T; Fujita H; Tani T; Ohte N
    Atherosclerosis; 2015 Apr; 239(2):311-7. PubMed ID: 25682029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
    Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
    Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma urokinase antigen and C-reactive protein predict angina recurrence after coronary angioplasty.
    Parfyonova Y; Alekseeva I; Plekhanova O; Deev A; Titaeva E; Dobrovolsky A; Gabbasov Z; Lyakishev A; Tkachuk V
    Heart Vessels; 2014 Sep; 29(5):611-8. PubMed ID: 24057344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.
    Kothari H; Nguyen AT; Yang X; Hisada Y; Tsimikas S; Mackman N; Taylor A; McNamara CA
    J Cardiovasc Transl Res; 2018 Jun; 11(3):221-229. PubMed ID: 29344841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
    Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
    J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.